 | • レポートコード：B-GIR09D2662 • 出版社/出版日：GlobalInfoResearch / 2019年9月11日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、124ページ • 納品方法：Eメール • 産業分類：医薬品・ヘルスケア |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、院内感染肺炎薬パイプライン分析の世界市場について調べ、まとめました。種類別セグメントは、リン酸テジゾリド、セフトロザン/タゾバクタム、セフタジジム/アビバクタム、アミカシン吸入、プラゾマイシン、シンフロリックスワクチン等、用途別セグメントは、細菌性肺炎、ウイルス性肺炎等に区分しました。院内感染肺炎薬パイプライン分析の世界市場概観、メーカー動向、メーカー別院内感染肺炎薬パイプライン分析シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・院内感染肺炎薬パイプライン分析の市場概観 ・院内感染肺炎薬パイプライン分析の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・院内感染肺炎薬パイプライン分析の企業別販売動向、市場シェア、市場集中度、競争動向 ・院内感染肺炎薬パイプライン分析の世界市場規模 ・院内感染肺炎薬パイプライン分析の北米市場分析（アメリカ、カナダ、メキシコ等） ・院内感染肺炎薬パイプライン分析のアメリカ市場規模推移 ・院内感染肺炎薬パイプライン分析のカナダ市場規模推移 ・院内感染肺炎薬パイプライン分析のメキシコ市場規模推移 ・院内感染肺炎薬パイプライン分析のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・院内感染肺炎薬パイプライン分析のドイツ市場規模推移 ・院内感染肺炎薬パイプライン分析のイギリス市場規模推移 ・院内感染肺炎薬パイプライン分析のロシア市場規模推移 ・院内感染肺炎薬パイプライン分析のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・院内感染肺炎薬パイプライン分析の日本市場規模推移 ・院内感染肺炎薬パイプライン分析の中国市場規模推移 ・院内感染肺炎薬パイプライン分析の韓国市場規模推移 ・院内感染肺炎薬パイプライン分析のインド市場規模推移 ・院内感染肺炎薬パイプライン分析の東南アジア市場規模推移 ・院内感染肺炎薬パイプライン分析の南米市場分析（ブラジル、アルゼンチン等） ・院内感染肺炎薬パイプライン分析の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・院内感染肺炎薬パイプライン分析の種類別分析/販売量、売上、市場シェア（リン酸テジゾリド、セフトロザン/タゾバクタム、セフタジジム/アビバクタム、アミカシン吸入、プラゾマイシン、シンフロリックスワクチン） ・院内感染肺炎薬パイプライン分析の用途別分析/市場規模（細菌性肺炎、ウイルス性肺炎） ・院内感染肺炎薬パイプライン分析の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・院内感染肺炎薬パイプライン分析の販売チャネル・代理店・貿易業者・ディーラー分析 |
Nosocomial or hospital acquired infections have created numerous complications for patients in hospitals throughout the world, as these infections are caused by multidrug resistant microorganisms, the recuperation of a patient is drastically reduced and accompanied by several comorbidities. Being multidrug resistant, these organisms are immune to the conventional antibiotics hence difficult to treat. Pneumonia is one of the prominent infections caused in hospital premises. Cases of hospital acquired pneumonia are common in immunocompromised patients, post surgical infections, enteral feeding, elderly and infant patients. As hospital acquired pneumonia is mainly caused as a result of prolonged exposure to ventilator air, it is also called as ventilator associated pneumonia. Major causative pathogens include methicillin resistant S. aureus (MRSA), multi drug resistant (MDR) P. aeruginosa, Klebsiella and Acinetobacter. Respiratory Syncytial Virus (RSV) has also been found to be a major causative agent of nosocomial pneumonia in new borne.
Scope of the Report:
The worldwide market for Pipeline Analysis of Hospital Acquired Pneumonia Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Pipeline Analysis of Hospital Acquired Pneumonia Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Achaogen
Aridis Pharmaceuticals
AstraZeneca
Cubist Pharmaceuticals
Meiji Seika Pharma
Merck
Sanofi
GlaxoSmithKline
Valneva
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Tedizolid Phosphate
Ceftolozane/Tazobactam
Ceftazidime/Avibactum
Amikacin Inhale
Plazomicin
Synflorix Vaccine
Market Segment by Applications, can be divided into
Bacterial Pneumonia
Viral Pneumonia
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pipeline Analysis of Hospital Acquired Pneumonia Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Pipeline Analysis of Hospital Acquired Pneumonia Drugs, with price, sales, revenue and global market share of Pipeline Analysis of Hospital Acquired Pneumonia Drugs in 2017 and 2018.
Chapter 3, the Pipeline Analysis of Hospital Acquired Pneumonia Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pipeline Analysis of Hospital Acquired Pneumonia Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Pipeline Analysis of Hospital Acquired Pneumonia Drugs market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Pipeline Analysis of Hospital Acquired Pneumonia Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Pipeline Analysis of Hospital Acquired Pneumonia Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Tedizolid Phosphate
1.2.2 Ceftolozane/Tazobactam
1.2.3 Ceftazidime/Avibactum
1.2.4 Amikacin Inhale
1.2.5 Plazomicin
1.2.6 Synflorix Vaccine
1.3 Market Analysis by Applications
1.3.1 Bacterial Pneumonia
1.3.2 Viral Pneumonia
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Achaogen
2.1.1 Business Overview
2.1.2 Pipeline Analysis of Hospital Acquired Pneumonia Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Achaogen Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Aridis Pharmaceuticals
2.2.1 Business Overview
2.2.2 Pipeline Analysis of Hospital Acquired Pneumonia Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Aridis Pharmaceuticals Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 AstraZeneca
2.3.1 Business Overview
2.3.2 Pipeline Analysis of Hospital Acquired Pneumonia Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 AstraZeneca Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Cubist Pharmaceuticals
2.4.1 Business Overview
2.4.2 Pipeline Analysis of Hospital Acquired Pneumonia Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Cubist Pharmaceuticals Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Meiji Seika Pharma
2.5.1 Business Overview
2.5.2 Pipeline Analysis of Hospital Acquired Pneumonia Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Meiji Seika Pharma Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Merck
2.6.1 Business Overview
2.6.2 Pipeline Analysis of Hospital Acquired Pneumonia Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Merck Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Sanofi
2.7.1 Business Overview
2.7.2 Pipeline Analysis of Hospital Acquired Pneumonia Drugs Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Sanofi Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 GlaxoSmithKline
2.8.1 Business Overview
2.8.2 Pipeline Analysis of Hospital Acquired Pneumonia Drugs Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 GlaxoSmithKline Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 Valneva
2.9.1 Business Overview
2.9.2 Pipeline Analysis of Hospital Acquired Pneumonia Drugs Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Valneva Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Pipeline Analysis of Hospital Acquired Pneumonia Drugs Manufacturer Market Share in 2018
3.3.2 Top 6 Pipeline Analysis of Hospital Acquired Pneumonia Drugs Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market Analysis by Regions
4.1 Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales and Market Share by Regions (2014-2019)
4.1.2 Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue and Market Share by Regions (2014-2019)
4.2 North America Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales and Growth Rate (2014-2019)
4.3 Europe Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales and Growth Rate (2014-2019)
4.5 South America Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales and Growth Rate (2014-2019)
5 North America Pipeline Analysis of Hospital Acquired Pneumonia Drugs by Country
5.1 North America Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales and Market Share by Country (2014-2019)
5.1.2 North America Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue and Market Share by Country (2014-2019)
5.2 United States Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales and Growth Rate (2014-2019)
5.3 Canada Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales and Growth Rate (2014-2019)
5.4 Mexico Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales and Growth Rate (2014-2019)
6 Europe Pipeline Analysis of Hospital Acquired Pneumonia Drugs by Country
6.1 Europe Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales and Market Share by Country (2014-2019)
6.1.2 Europe Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue and Market Share by Country (2014-2019)
6.2 Germany Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales and Growth Rate (2014-2019)
6.3 UK Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales and Growth Rate (2014-2019)
6.4 France Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales and Growth Rate (2014-2019)
6.5 Russia Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales and Growth Rate (2014-2019)
6.6 Italy Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales and Growth Rate (2014-2019)
7 Asia-Pacific Pipeline Analysis of Hospital Acquired Pneumonia Drugs by Country
7.1 Asia-Pacific Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue and Market Share by Country (2014-2019)
7.2 China Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales and Growth Rate (2014-2019)
7.3 Japan Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales and Growth Rate (2014-2019)
7.4 Korea Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales and Growth Rate (2014-2019)
7.5 India Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales and Growth Rate (2014-2019)
8 South America Pipeline Analysis of Hospital Acquired Pneumonia Drugs by Country
8.1 South America Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales and Market Share by Country (2014-2019)
8.1.2 South America Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue and Market Share by Country (2014-2019)
8.2 Brazil Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales and Growth Rate (2014-2019)
8.3 Argentina Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales and Growth Rate (2014-2019)
8.4 Colombia Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales and Growth Rate (2014-2019)
9 Middle East and Africa Pipeline Analysis of Hospital Acquired Pneumonia Drugs by Countries
9.1 Middle East and Africa Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales and Growth Rate (2014-2019)
9.3 Turkey Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales and Growth Rate (2014-2019)
9.4 Egypt Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales and Growth Rate (2014-2019)
9.5 Nigeria Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales and Growth Rate (2014-2019)
9.6 South Africa Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales and Growth Rate (2014-2019)
10 Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market Segment by Type
10.1 Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales and Market Share by Type (2014-2019)
10.1.2 Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue and Market Share by Type (2014-2019)
10.2 Tedizolid Phosphate Sales Growth and Price
10.2.1 Global Tedizolid Phosphate Sales Growth (2014-2019)
10.2.2 Global Tedizolid Phosphate Price (2014-2019)
10.3 Ceftolozane/Tazobactam Sales Growth and Price
10.3.1 Global Ceftolozane/Tazobactam Sales Growth (2014-2019)
10.3.2 Global Ceftolozane/Tazobactam Price (2014-2019)
10.4 Ceftazidime/Avibactum Sales Growth and Price
10.4.1 Global Ceftazidime/Avibactum Sales Growth (2014-2019)
10.4.2 Global Ceftazidime/Avibactum Price (2014-2019)
10.5 Amikacin Inhale Sales Growth and Price
10.5.1 Global Amikacin Inhale Sales Growth (2014-2019)
10.5.2 Global Amikacin Inhale Price (2014-2019)
10.6 Plazomicin Sales Growth and Price
10.6.1 Global Plazomicin Sales Growth (2014-2019)
10.6.2 Global Plazomicin Price (2014-2019)
10.7 Synflorix Vaccine Sales Growth and Price
10.7.1 Global Synflorix Vaccine Sales Growth (2014-2019)
10.7.2 Global Synflorix Vaccine Price (2014-2019)
11 Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market Segment by Application
11.1 Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales Market Share by Application (2014-2019)
11.2 Bacterial Pneumonia Sales Growth (2014-2019)
11.3 Viral Pneumonia Sales Growth (2014-2019)
12 Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market Forecast (2019-2024)
12.1 Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales, Revenue and Growth Rate (2019-2024)
12.2 Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market Forecast by Regions (2019-2024)
12.2.1 North America Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market Forecast (2019-2024)
12.2.2 Europe Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market Forecast (2019-2024)
12.2.3 Asia-Pacific Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market Forecast (2019-2024)
12.2.4 South America Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market Forecast (2019-2024)
12.2.5 Middle East and Africa Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market Forecast (2019-2024)
12.3 Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market Forecast by Type (2019-2024)
12.3.1 Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales Forecast by Type (2019-2024)
12.3.2 Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market Share Forecast by Type (2019-2024)
12.4 Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market Forecast by Application (2019-2024)
12.4.1 Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales Forecast by Application (2019-2024)
12.4.2 Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
Figure Pipeline Analysis of Hospital Acquired Pneumonia Drugs Picture
Table Product Specifications of Pipeline Analysis of Hospital Acquired Pneumonia Drugs
Figure Global Sales Market Share of Pipeline Analysis of Hospital Acquired Pneumonia Drugs by Types in 2018
Table Pipeline Analysis of Hospital Acquired Pneumonia Drugs Types for Major Manufacturers
Figure Tedizolid Phosphate Picture
Figure Ceftolozane/Tazobactam Picture
Figure Ceftazidime/Avibactum Picture
Figure Amikacin Inhale Picture
Figure Plazomicin Picture
Figure Synflorix Vaccine Picture
Figure Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales Market Share by Applications in 2018
Figure Bacterial Pneumonia Picture
Figure Viral Pneumonia Picture
Figure United States Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure France Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure UK Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure China Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure India Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue (Value) and Growth Rate (2014-2024)
Table Achaogen Basic Information, Manufacturing Base and Competitors
Table Achaogen Pipeline Analysis of Hospital Acquired Pneumonia Drugs Type and Applications
Table Achaogen Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Aridis Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Aridis Pharmaceuticals Pipeline Analysis of Hospital Acquired Pneumonia Drugs Type and Applications
Table Aridis Pharmaceuticals Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Pipeline Analysis of Hospital Acquired Pneumonia Drugs Type and Applications
Table AstraZeneca Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Cubist Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Cubist Pharmaceuticals Pipeline Analysis of Hospital Acquired Pneumonia Drugs Type and Applications
Table Cubist Pharmaceuticals Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Meiji Seika Pharma Basic Information, Manufacturing Base and Competitors
Table Meiji Seika Pharma Pipeline Analysis of Hospital Acquired Pneumonia Drugs Type and Applications
Table Meiji Seika Pharma Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Pipeline Analysis of Hospital Acquired Pneumonia Drugs Type and Applications
Table Merck Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Pipeline Analysis of Hospital Acquired Pneumonia Drugs Type and Applications
Table Sanofi Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline Pipeline Analysis of Hospital Acquired Pneumonia Drugs Type and Applications
Table GlaxoSmithKline Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Valneva Basic Information, Manufacturing Base and Competitors
Table Valneva Pipeline Analysis of Hospital Acquired Pneumonia Drugs Type and Applications
Table Valneva Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales by Manufacturer (2017-2018)
Figure Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales Market Share by Manufacturer in 2017
Figure Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales Market Share by Manufacturer in 2018
Table Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue by Manufacturer (2017-2018)
Figure Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue Market Share by Manufacturer in 2017
Figure Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue Market Share by Manufacturer in 2018
Figure Top 3 Pipeline Analysis of Hospital Acquired Pneumonia Drugs Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Pipeline Analysis of Hospital Acquired Pneumonia Drugs Manufacturer (Revenue) Market Share in 2018
Figure Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales and Growth Rate (2014-2019)
Figure Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue and Growth Rate (2014-2019)
Table Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales by Regions (2014-2019)
Table Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales Market Share by Regions (2014-2019)
Table Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue by Regions (2014-2019)
Figure Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue Market Share by Regions in 2014
Figure Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue Market Share by Regions in 2018
Figure North America Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales and Growth Rate (2014-2019)
Figure Europe Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales and Growth Rate (2014-2019)
Figure South America Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales and Growth Rate (2014-2019)
Figure North America Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue and Growth Rate (2014-2019)
Table North America Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales by Countries (2014-2019)
Table North America Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales Market Share by Countries (2014-2019)
Figure North America Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales Market Share by Countries in 2014
Figure North America Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales Market Share by Countries in 2018
Table North America Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue by Countries (2014-2019)
Table North America Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue Market Share by Countries (2014-2019)
Figure North America Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue Market Share by Countries in 2014
Figure North America Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue Market Share by Countries in 2018
Figure United States Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales and Growth Rate (2014-2019)
Figure Canada Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales and Growth Rate (2014-2019)
Figure Mexico Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales and Growth Rate (2014-2019)
Figure Europe Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue and Growth Rate (2014-2019)
Table Europe Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales by Countries (2014-2019)
Table Europe Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales Market Share by Countries (2014-2019)
Table Europe Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue by Countries (2014-2019)
Figure Europe Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue Market Share by Countries in 2017
Figure Europe Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue Market Share by Countries in 2018
Figure Germany Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales and Growth Rate (2014-2019)
Figure UK Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales and Growth Rate (2014-2019)
Figure France Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales and Growth Rate (2014-2019)
Figure Russia Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales and Growth Rate (2014-2019)
Figure Italy Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales by Countries (2014-2019)
Table Asia-Pacific Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales Market Share by Countries 2018
Table Asia-Pacific Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue by Countries (2014-2019)
Figure Asia-Pacific Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue Market Share by Countries 2018
Figure China Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales and Growth Rate (2014-2019)
Figure Japan Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales and Growth Rate (2014-2019)
Figure Korea Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales and Growth Rate (2014-2019)
Figure India Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales and Growth Rate (2014-2019)
Figure Southeast Asia Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales and Growth Rate (2014-2019)
Figure South America Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue and Growth Rate (2014-2019)
Table South America Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales by Countries (2014-2019)
Table South America Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales Market Share by Countries (2014-2019)
Figure South America Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales Market Share by Countries in 2018
Table South America Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue by Countries (2014-2019)
Table South America Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue Market Share by Countries (2014-2019)
Figure South America Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue Market Share by Countries in 2018
Figure Brazil Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales and Growth Rate (2014-2019)
Figure Argentina Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales and Growth Rate (2014-2019)
Figure Colombia Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales by Countries (2014-2019)
Table Middle East and Africa Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales Market Share by Countries in 2018
Table Middle East and Africa Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue by Countries (2014-2019)
Table Middle East and Africa Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue Market Share by Countries in 2014
Figure Middle East and Africa Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue Market Share by Countries in 2018
Figure Saudi Arabia Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales and Growth Rate (2014-2019)
Figure UAE Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales and Growth Rate (2014-2019)
Figure Egypt Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales and Growth Rate (2014-2019)
Figure Nigeria Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales and Growth Rate (2014-2019)
Figure South Africa Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales and Growth Rate (2014-2019)
Table Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales by Type (2014-2019)
Table Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales Share by Type (2014-2019)
Table Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue by Type (2014-2019)
Table Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue Share by Type (2014-2019)
Figure Global Tedizolid Phosphate Sales Growth (2014-2019)
Figure Global Tedizolid Phosphate Price (2014-2019)
Figure Global Ceftolozane/Tazobactam Sales Growth (2014-2019)
Figure Global Ceftolozane/Tazobactam Price (2014-2019)
Figure Global Ceftazidime/Avibactum Sales Growth (2014-2019)
Figure Global Ceftazidime/Avibactum Price (2014-2019)
Figure Global Amikacin Inhale Sales Growth (2014-2019)
Figure Global Amikacin Inhale Price (2014-2019)
Figure Global Plazomicin Sales Growth (2014-2019)
Figure Global Plazomicin Price (2014-2019)
Figure Global Synflorix Vaccine Sales Growth (2014-2019)
Figure Global Synflorix Vaccine Price (2014-2019)
Table Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales by Application (2014-2019)
Table Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales Share by Application (2014-2019)
Figure Global Viral Pneumonia Sales Growth (2014-2019)
Figure Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales, Revenue and Growth Rate (2019-2024)
Table Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales Forecast by Regions (2019-2024)
Table Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market Share Forecast by Regions (2019-2024)
Figure North America Sales Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market Forecast (2019-2024)
Figure Europe Sales Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market Forecast (2019-2024)
Figure Asia-Pacific Sales Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market Forecast (2019-2024)
Figure South America Sales Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market Forecast (2019-2024)
Figure Middle East and Africa Sales Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market Forecast (2019-2024)
Table Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales Forecast by Type (2019-2024)
Table Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market Share Forecast by Type (2019-2024)
Table Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales Forecast by Application (2019-2024)
Table Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List
世界のイロプロスト薬市場予測（～2024年） Iloprost is a drug used to treat pulmonary arterial hypertension (PAH), scleroderma, Raynaud's phenomenon and other diseases in which the blood vessels are constricted and blood can't flow to the tissues. Scope of the Report: The worldwide market for Iloprost Drugs is expected to grow at a CAGR of …- 世界のエポプロステノールナトリウム薬市場予測（～2024年） Epoprostenol sodium directly simulates prostaglandin receptors in arterial vascular smooth muscle, thereby causing vasodilatation. Scope of the Report: The worldwide market for Epoprostenol Sodium Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ …
- 世界のめまい薬市場予測（～2024年） Vertigo is a symptom of several different health conditions such as labyrinthitis and meniere's disease. Scope of the Report: The worldwide market for Vertigo Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, …
- 世界のポルフィリン症薬市場予測（～2024年） Porphyria is a group of diseases in which substances called porphyrins build up, negatively affecting the skin or nervous system. Scope of the Report: The worldwide market for Porphyrias Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, f…
- 世界の酒さ薬市場予測（～2024年） Rosacea is a common skin condition characterized by redness and visible blood vessels on the face. The nose and cheeks are the most affected regions. The signs and symptoms of Rosacea are small, red, pus-filled bumps which may flare up periodically. About half the patients experience eye dryness, ir…